ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2026
Actionable Steps to Address Disparities in Healthcare Among US Patients With Multiple Myeloma: A Patient Perspective.
Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Patients with multiple myeloma (MM), patient advocates, healthcare providers (HCPs), and industry sponsors gathered at 2 MM Health Equity Summits to discuss their experiences and perspectives on MM healthcare inequities in the US. Eight topics relevant to the patient experience were identified at the first summit, prioritized by participant survey, and aligned on by the entire group. Two topics were then selected for priority discussion in the follow-up summit, which led to the insights presented here and actionable steps for US HCPs, policy makers, and other stakeholders. The first topic centered around delivering precise information specific to a patient’s disease journey, emphasizing awareness and understanding. Lack of MM awareness and its symptoms among non-specialist HCPs and patients was identified as the primary cause for delayed diagnoses in patients with generalized symptoms. Participants suggested that enhancing HCP MM trainings and resources may aid timely diagnoses. Furthermore, using diverse communication channels and leveraging support groups and community health workers may improve MM education for patients, caregivers, and other family members and promote self-advocacy. The second topic focused on improving access to optimal care. Participants discussed how geographical, cultural, and financial factors influence access to specialized treatment. Proposed solutions included telehealth, reducing potential HCP biases in referrals, and using patient navigators to aid with insurance obstacles. Participants also discussed ways to improve perceptions of clinical trials. The MM Health Equity Summits allowed patients and patient advocates to discuss experiences and treatment access barriers. Actionable steps were recommended for HCPs and policymakers to improve treatment of disadvantaged patients, redressing historic inequities, and focusing on solutions to expand awareness, understanding, and access to healthcare.
Indexed as
Identifiers
41543683What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.